Loading clinical trials...
Loading clinical trials...
PARASTOP - Paracetamol With Strong Opioids. A Randomized, Double-blind, Parallel-group Non-inferiority Phase III Withdrawal Trial of Paracetamol Versus Placebo in Conjunction With Opioids for Moderate to Severe Cancer-related Pain
Conditions
Interventions
Paracetamol
Placebo
Locations
15
Italy
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Italy
Vestre Viken Hospital Trust
Drammen, Drammen, Norway
Førde Hospital Trust
Førde, Førde, Norway
Østfold Hospital Trust
Sarpsborg, Grålum, Norway
Sørlandet Hospital Trust
Kristiansand, Kristiansand, Norway
Stavanger University Hospital
Stavanger, Stavanger, Norway
Start Date
October 20, 2021
Primary Completion Date
February 11, 2026
Completion Date
February 18, 2026
Last Updated
February 25, 2026
NCT05468034
NCT04541381
NCT06043817
NCT05398783
NCT07489378
NCT03137095
Lead Sponsor
Oslo University Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions